Høyvik AJK, Stenberg VY, Liukaityte R, Repetto-Llamazares A, Peng Q, Wangen-Riise R, Wiig E, Ma LW, Revheim ME, Juzeniene A(2025) Optimizing [212Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts J Nucl Med(in press) DOI 10.2967/jnumed.125.270444, PubMed 41043994
Alampi MM, Kozlíková M, Mariangeli M, Civita S, Delcanale P, Mussini A, Diaspro A, Bianchini P, Weyergang A, Skarpen E, Berg K, Viappiani C, Abbruzzetti S, Selbo PK(2025) Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab Biomed Pharmacother, 191, 118550 DOI 10.1016/j.biopha.2025.118550, PubMed 40946581
Switlyk MD, Dale E, Tafjord S, Willumsen L, Hole KH, Hompland T(2025) Reduced field-of-view DWI outperforms conventional DWI in assessing tumor heterogeneity and HPV status in head and neck cancer Sci Rep, 15(1), 31889 DOI 10.1038/s41598-025-17284-8, PubMed 40883428
Get in touch
Contact information Pål Kristian Selbo Department of Radiation Biology, Institute for Cancer Research Norwegian Radium Hospital, Oslo University Hospital Phone +47 2278 1469, e-mail: paasel@ous-hf.no
